NCT04729322 2025-12-23Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-respondersM.D. Anderson Cancer CenterPhase 2 Active not recruiting15 enrolled